LEADER 01273nam  2200349Ia 450 
001 9910698855603321
005 20090514134957.0
035   $a(CKB)5470000002397309
035   $a(OCoLC)320959242
035   $a(EXLCZ)995470000002397309
100   $a20090514d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ebiological product deviation reporting for blood and plasma establishments
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2006]
215   $a30 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 14, 2009).
300   $a"October 2006".
320   $aIncludes bibliographical references (page 30).
517   $aGuidance for industry 
606   $aBlood banks$xGovernment policy$zUnited States
615  0$aBlood banks$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698855603321
996   $aGuidance for industry$93434577
997   $aUNINA